What Happened?
Lexington, MA-based Translate Bio Promoted Greg Troiano as Chief Manufacturing Officer and Senior Vice President of Technical Operations
About the Company
Translate Bio is a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. Our proprietary mRNA therapeutic platform (MRTTM) is designed to develop product candidates that deliver mRNA carrying instructions to produce intracellular, transmembrane and secreted proteins for therapeutic benefit. We believe that our MRTTM platform is applicable to a broad range of diseases caused by insufficient protein production or where production of proteins can modify disease, including diseases that affect the lung, liver, eye, central nervous system, lymphatic system and circulatory system. Our two lead programs are being developed as treatments for cystic fibrosis (CF) and ornithine transcarbamylase (OTC) deficiency.
About the Person
Greg Troiano is Chief Manufacturing Officer and Senior Vice President of Technical Operations at Translate Bio. Previously, Greg held various senior IT leadership roles in the industry.
Info Source
News
Short Profile